Log In
Sunday 18th February 2018

New trial stage for TB vaccine

27th April 2009

Scientists at Oxford University have said the vaccine MVA85A is to be trialled on young children to see if it is effective against tuberculosis. 

2,784 children in South Africa will be given the vaccine, which stimulates T-cells in the immune system to respond more strongly to the BCG injection. Oxford University researcher Dr Helen McShane said: "This trial will hopefully show that the vaccine can protect people from getting TB."

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018